Latam SOLACI-EuroPCR Session

Once more, SOLACI is proud to participate at one of the most important interventional cardiology meetings in the world: the EuroPCR 2019.

Together with our European sister institution, we will conduct an important joint session on “Innovations for the treatment of complex coronary artery lesions from LATAM”, where we will touch upon topics related to STEMI, CTO and coronary interventions.

The activity will take place on Tuesday May 21st in room 252A of Palais des Congress. Pestigious Latin American professionals from SOLACI and Dr. Corrado Tamburino, from Italy, will be there. In this sense, you will be able to enjoy the presentations of doctors José Luis Leiva Pons (SOLACI President, from Mexico), Anibal Damonte (Argentina), Marco Antonio Alcocer Gamba (Mexico), Guering Eid Lidt (Mexico), Alexandre Quadros (Brazil) and Carlos Uribe (Colombia).  

We invite the whole Latin American medical community to participate in this activity, which expresses SOLACI and EuroPCR’s wish to keep deepening their international collaboration, to exchange fruitful experiences that will allow us to advance and improve our patients’ quality of life.

Session Info

  • Tuesday, May 21st, 2019.
  • 12.00 am – 1 pm;
  • Room 252A / Level 2.

More info on this Congress

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...